Extracorporeal whole blood immunoadsorption of autoimmune myasthenia gravis by cellulose tryptophan adsorbent

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 32, Issue 4, 2004, Pages 519-528

  Yang, Li ^a   Cheng, Yan ^a   Yan, Wei Rong ^b   Yu, Yao Ting ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Antibody; Biocompatibility; Experimental autoimmune myasthenia gravis; Neuromuscular transmission function; Whole blood immunoadsorption

Indexed keywords

ADSORBENTS; ADSORPTION; ANTIBODIES; CELLS; CELLULOSE; ELECTROLYTES; IMMUNOLOGY; MUSCLE; NEUROLOGY; SYNTHESIS (CHEMICAL);

ACETYLCHOLINE RECEPTOR; IMMUNOADSORPTION; MUSCLE ACTION POTENTIAL; WHOLE BLOOD IMMUNOADSORPTION (WBIA) SYSTEM;

BLOOD;

ADSORBENT; ANTIBODY; CELLULOSE; CHOLINERGIC RECEPTOR; ELECTROLYTE; GLOBULIN; PEPTIDE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BIOCOMPATIBILITY; BLOOD CELL; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMALE; IMMUNOADSORPTION; MUSCLE ACTION POTENTIAL; MYASTHENIA GRAVIS; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PROTEIN BINDING; RABBIT; SYNTHESIS;

ANIMALS; AUTOANTIBODIES; CELLULOSE; FEMALE; HEMOFILTRATION; IMMUNOSORBENTS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RABBITS; RECEPTORS, CHOLINERGIC; TRYPTOPHAN;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 10644238102     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIO-200039610     Document Type: Article

References (10)

1. Angela, V., Jackle, P., David, H. J. (2001). Myasthenia gravis. Lancet 357:2122-2128.
2. Grob, D., Simpson, D., Mitsumoto, H., Hoch, B., Mokhtarian, F., Bender, A., Greenberg, M., Koo, A., Nakayama, S. (1995). Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45:338-344.
3. Karussis, D. M., Lehmann, D., Brenner, T., Wirguin, I., Mizrachi-Koll, R., Sicsic, C., Abramsky, O. (1994). Immunomodulation of experimental autoimmune myasthenia gravis with Linomide. Journal of Neuroimmunology 55:187-93.
4. Kong, D. L., Chen, C. Z., Lin, E. F., Yu, Y. T. (1998). Clinical trials of type I and in vitro studies of type II immunoadsorbents for systemic lupus erythematosus therapy. Artificial Organs 22(8):644-650.
5. Lindstrom, J. M. (2000). Acetylcholine receptors myasthenia. Muscle & Nerve 453-477.
6. Masaharu, T., Seiichi, O., Miwako, N., Hiroaki, Yoshikawa. (1988). Myasthenogenic significance of synthetic a-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor. Journal of the Neuronological Sciences 85:121-129.
7. Premkumar, C., Mathildle, P., Deng, C. S. (2000). Animal models of myasthenia gravis. Clin. Immuno. 94(2):75-87.
8. Shibuya, N., Sato, T., Osame, M., Takegami, T., Doi, S., Kawanami, S. (1994). Immunoadsorption therapy for myasthenia gravis. J. Neuro. Neurosur. Ps. 57:578-581.
9. Yan, W. R., Yu, Y. T., Yang, L. (2002). Studies on new immunoadsorbent for myasthenia gravis. Chemical Journal of Chinese Universities 23(10): 1887-1890.
10. Yoshida, M., Tamura, Y., Yamada, Y., Yamawaki, N., Yamashita, Y., Immusorba, T. R., Immusorba, P. H. (2000). Basics of design and features of functions. Ther. Apher. 4(2):127-134.